| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.5 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |